Page last updated: 2024-08-16

sulforaphane and pp242

sulforaphane has been researched along with pp242 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hou, G; Li, Y; Lu, Z; Wang, P; Wei, H; Xu, Y; Zhang, Y; Zhao, W	1

Other Studies

1 other study(ies) available for sulforaphane and pp242

Article	Year
mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma. Molecular biology reports, 2022, Volume: 49, Issue:1 Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Esophageal Neoplasms; Humans; Immunophenotyping; Indoles; Isothiocyanates; Mice; Models, Biological; MTOR Inhibitors; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; Sulfoxides; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2022

Article

Year

mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma.

Molecular biology reports, 2022, Volume: 49, Issue:1

Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Esophageal Neoplasms; Humans; Immunophenotyping; Indoles; Isothiocyanates; Mice; Models, Biological; MTOR Inhibitors; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; Sulfoxides; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2022